Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial
Sorensen, Per Soelberg, Prof, Lycke, Jan, MD, Erälinna, Juha-Pekka, MD, Edland, Astrid, MD, Wu, Xingchen, MD, Frederiksen, Jette Lautrup, MD, Oturai, Annette, MD, Malmeström, Clas, MD, Stenager, Egon, MD, Sellebjerg, Finn, MD, Sondergaard, Helle Bach, MS
Published in Lancet neurology (01.08.2011)
Published in Lancet neurology (01.08.2011)
Get full text
Journal Article
Evolving concepts in the treatment of relapsing multiple sclerosis
Comi, Giancarlo, Prof, Radaelli, Marta, MD, Soelberg Sørensen, Per, Prof
Published in The Lancet (British edition) (01.04.2017)
Published in The Lancet (British edition) (01.04.2017)
Get full text
Journal Article
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis
Giovannoni, Gavin, Prof, Cook, Stuart, Prof, Rammohan, Kottil, Prof, Rieckmann, Peter, MD, Sørensen, Per Soelberg, Prof, Vermersch, Patrick, Prof, Hamlett, Anthony, PhD, Viglietta, Vissia, MD, Greenberg, Steven, MD
Published in Lancet neurology (01.04.2011)
Published in Lancet neurology (01.04.2011)
Get full text
Journal Article
Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis
Polman, Chris H, Prof, Bertolotto, Antonio, MD, Deisenhammer, Florian, Prof, Giovannoni, Gavin, Prof, Hartung, Hans-Peter, Prof, Hemmer, Bernhard, Prof, Killestein, Joep, MD, McFarland, Henry F, MD, Oger, Joel, Prof, Pachner, Andrew R, Prof, Petkau, John, Prof, Reder, Anthony T, MD, Reingold, Stephen C, PhD, Schellekens, Huub, Prof, Sørensen, Per Soelberg, Prof
Published in Lancet neurology (01.07.2010)
Published in Lancet neurology (01.07.2010)
Get full text
Journal Article
Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial
Ravnborg, Mads, MD, Sørensen, Per Soelberg, Prof, Andersson, Magnus, MD, Celius, Elisabeth G, MD, Jongen, Peter J, MD, Elovaara, Irina, MD, Bartholomé, Emmanuel, MD, Constantinescu, Cris S, MD, Beer, Karsten, MD, Garde, Ellen, MD, Sperling, Bjørn, MD
Published in Lancet neurology (01.07.2010)
Published in Lancet neurology (01.07.2010)
Get full text
Journal Article